NCT03284385 2025-10-27Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2National Cancer Institute (NCI)Phase 2 Active not recruiting60 enrolled
NCT04197713 2025-10-20Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR StudyNational Cancer Institute (NCI)Phase 1 Active not recruiting13 enrolled 13 charts